Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research ...

The discovery of a gut-to-brain regulation pathway in flies highlights the potential for certain medications to be further ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

According to a new study, however, that may be changing. The team of researchers in China came up with a treatment that used ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Drug discovery researchers have found that a natural fat molecule called 'lipoxin A4' (LXA4) could significantly reduce inflammation and improve function for diabetic hearts.

Amneal Pharmaceuticals resubmitted a new drug application for its migraine treatment to the Food and Drug Administration, and additionally received approval for its diabetes and obesity treatment. The ...

New classes of drugs like the SGLT-2 Inhibitors and GLP-1 Receptor Agonists  have tremendous potential for managing the blood ...

Stress hormones, not impaired insulin signaling, may underlie obesity-related diabetes, according to Rutgers research.

Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.